Sign Out
Jakavi 5 mg tablets: Round curved white to almost white tablets of approximately 7.5 mm in diameter with "NVR" debossed on one side and "L5" debossed on the other side.
Each tablet contains 5 mg ruxolitinib (as phosphate).
Jakavi 15 mg tablets: Ovaloid curved white to almost white tablets of approximately 15.0 x 7.0 mm with "NVR" debossed on one side and "L15" debossed on the other side.
Each tablet contains 15 mg ruxolitinib (as phosphate).
Jakavi 20 mg tablets: Elongated curved white to almost white tablets of approximately 16.5 x 7.4 mm with "NVR" debossed on one side and "L20" debossed on the other side.
Each tablet contains 20 mg ruxolitinib (as phosphate).
Excipient with known effect: Jakavi 5 mg tablets: Each tablet contains 71.45 mg lactose monohydrate.
Jakavi 15 mg tablets: Each tablet contains 214.35 mg lactose monohydrate.
Jakavi 20 mg tablets: Each tablet contains 285.80 mg lactose monohydrate.
Excipients/Inactive Ingredients: Microcrystalline cellulose, Magnesium stearate, Colloidal anhydrous silica, Sodium starch glycolate (Type A), Povidone, Hydroxypropylcellulose, Lactose monohydrate.
Continue with Google